Breakdown | Mar 2025 | Mar 2023 | Mar 2024 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 10.96B | 6.87B | 8.12B | 6.53B | 3.83B |
Gross Profit | 1.89B | 1.14B | 1.19B | 333.02M | 204.06M |
EBITDA | 801.83M | 786.23M | 787.54M | 747.37M | 2.94B |
Net Income | 248.21M | 126.23M | 209.45M | 93.77M | 1.96B |
Balance Sheet | |||||
Total Assets | 6.55B | 4.99B | 5.66B | 4.90B | 4.66B |
Cash, Cash Equivalents and Short-Term Investments | 128.98M | 1.45B | 13.15M | 1.19B | 1.02B |
Total Debt | 2.17B | 2.51B | 2.35B | 2.76B | 3.06B |
Total Liabilities | 5.09B | 4.00B | 4.45B | 4.04B | 3.89B |
Stockholders Equity | 1.45B | 995.18M | 1.20B | 865.10M | 771.33M |
Cash Flow | |||||
Free Cash Flow | 534.92M | 633.97M | 454.16M | 590.56M | 523.73M |
Operating Cash Flow | 1.09B | 722.90M | 738.63M | 708.04M | 576.72M |
Investing Cash Flow | -556.01M | -84.90M | -284.95M | -112.55M | -50.81M |
Financing Cash Flow | -519.71M | -569.91M | -507.38M | -621.48M | -529.91M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | ₹5.50B | 67.18 | ― | 2.99% | 45.21% | ||
66 Neutral | ₹1.89B | 14.36 | ― | -7.58% | 110.88% | ||
61 Neutral | ₹4.53B | 39.45 | ― | 29.52% | -57.95% | ||
57 Neutral | ₹4.00B | 26.88 | ― | 9.32% | -26.41% | ||
49 Neutral | ₹1.59B | ― | ― | -19.80% | -165.56% | ||
44 Neutral | C$923.76M | -8.68 | -0.23% | 2.69% | 24.53% | -41.45% | |
39 Underperform | ₹4.02B | ― | ― | -15.44% | -618.48% |
Bedmutha Industries Limited has announced the receipt of a compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ending June 30, 2025. This certificate, issued by MUFG Intime India Private Limited, confirms that the securities received for dematerialization during the quarter were processed and listed on the stock exchanges where previously issued securities are listed. This compliance ensures that the company’s securities management aligns with regulatory requirements, potentially enhancing investor confidence and maintaining its market credibility.